(+)-alpha-viniferin multiple interactions ISO RGD:1550709 6480464 alpha-viniferin inhibits the reaction [IFNG protein results in increased expression of CXCL10 mRNA] more ... CTD PMID:20424383 (+)-catechin multiple interactions ISO RGD:1352024 6480464 Catechin inhibits the reaction [S100B protein results in increased expression of CXCL10 mRNA] CTD PMID:17103373 (-)-demecolcine increases expression ISO RGD:1352024 6480464 Demecolcine results in increased expression of CXCL10 mRNA CTD PMID:23649840 (-)-epigallocatechin 3-gallate multiple interactions ISO RGD:1352024 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CXCL10 mRNA CTD PMID:22079256 1,2-dimethylhydrazine increases expression EXP 6480464 1, 2-Dimethylhydrazine results in increased expression of CXCL10 mRNA CTD PMID:27840820 1,4-phenylenediamine decreases expression ISO RGD:1550709 6480464 4-phenylenediamine results in decreased expression of CXCL10 mRNA CTD PMID:23445166 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1550709 6480464 Dinitrochlorobenzene results in increased expression of CXCL10 mRNA CTD PMID:19647056 , PMID:21404309 1-chloro-2,4-dinitrobenzene multiple interactions ISO RGD:1550709 6480464 NFE2L2 protein inhibits the reaction [Dinitrochlorobenzene results in increased expression of CXCL10 mRNA] CTD PMID:28219650 1-chloro-2,4-dinitrobenzene affects expression ISO RGD:1550709 6480464 Dinitrochlorobenzene affects the expression of CXCL10 mRNA CTD PMID:28219650 1-chloro-2,4-dinitrobenzene increases expression ISO RGD:1352024 6480464 Dinitrochlorobenzene results in increased expression of CXCL10 mRNA CTD PMID:20146380 1-fluoro-2,4-dinitrobenzene increases expression ISO RGD:1550709 6480464 Dinitrofluorobenzene results in increased expression of CXCL10 mRNA, Dinitrofluorobenzene results in increased expression of CXCL10 protein CTD PMID:15719370 1-fluoro-2,4-dinitrobenzene decreases expression ISO RGD:1550709 6480464 Dinitrofluorobenzene results in decreased expression of CXCL10 mRNA CTD PMID:23445166 1-naphthyl isothiocyanate increases expression EXP 6480464 1-Naphthylisothiocyanate results in increased expression of CXCL10 mRNA CTD PMID:25380136 1-naphthyl isothiocyanate multiple interactions ISO RGD:1352024 6480464 [1-Naphthylisothiocyanate co-treated with Cholic Acids] affects the expression of CXCL10 mRNA CTD PMID:27344345 1-naphthyl isothiocyanate affects expression EXP 6480464 1-Naphthylisothiocyanate affects the expression of CXCL10 protein CTD PMID:25051504 1-nitropyrene increases expression ISO RGD:1352024 6480464 1-nitropyrene results in increased expression of CXCL10 mRNA CTD PMID:19428942 , PMID:19879285 1-O-(alpha-D-galactosyl)-N-hexacosanoylphytosphingosine increases expression ISO RGD:1352024 6480464 KRN 7000 results in increased expression of CXCL10 protein CTD PMID:15867097 17alpha-ethynylestradiol decreases expression EXP 6480464 Ethinyl Estradiol results in decreased expression of CXCL10 protein CTD PMID:25051504 17alpha-ethynylestradiol multiple interactions ISO RGD:1550709 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXCL10 mRNA CTD PMID:17942748 17alpha-ethynylestradiol decreases expression ISO RGD:1550709 6480464 Ethinyl Estradiol results in decreased expression of CXCL10 mRNA CTD PMID:15885639 17beta-estradiol increases expression ISO RGD:1352024 6480464 Estradiol results in increased expression of CXCL10 mRNA, Estradiol results in increased expression of CXCL10 protein CTD PMID:15557169 17beta-estradiol multiple interactions ISO RGD:1352024 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CXCL10 mRNA more ... CTD PMID:15557169 more ... 17beta-estradiol multiple interactions ISO RGD:1550709 6480464 Estradiol inhibits the reaction [Dimethoate results in increased expression of CXCL10 mRNA] more ... CTD PMID:19533603 , PMID:23943137 2,2',4,4'-Tetrabromodiphenyl ether affects expression ISO RGD:1550709 6480464 2 more ... CTD PMID:30294300 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1352024 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXCL10 mRNA CTD PMID:20106945 2,3,7,8-tetrachlorodibenzodioxine decreases expression EXP 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXCL10 mRNA CTD PMID:32109520 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1352024 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL10 mRNA CTD PMID:28351761 2,3,7,8-tetrachlorodibenzodioxine increases expression ISO RGD:1550709 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL10 mRNA CTD PMID:23238561 , PMID:26290441 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CXCL10 mRNA CTD PMID:15644576 more ... 2,3,7,8-tetrachlorodibenzodioxine affects expression ISO RGD:1352024 6480464 Tetrachlorodibenzodioxin affects the expression of CXCL10 mRNA CTD PMID:22298810 2,3,7,8-tetrachlorodibenzodioxine decreases expression ISO RGD:1550709 6480464 Tetrachlorodibenzodioxin results in decreased expression of CXCL10 mRNA CTD PMID:19770486 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1550709 6480464 [Tetrachlorodibenzodioxin co-treated with Ethinyl Estradiol] results in increased expression of CXCL10 mRNA CTD PMID:17942748 2,4,6-trinitrobenzenesulfonic acid increases expression ISO RGD:1550709 6480464 Trinitrobenzenesulfonic Acid results in increased expression of CXCL10 protein CTD PMID:23596210 2,4,6-trinitrotoluene affects expression EXP 6480464 Trinitrotoluene affects the expression of CXCL10 mRNA CTD PMID:21346803 2,4-dinitrotoluene affects expression EXP 6480464 2, 4-dinitrotoluene affects the expression of CXCL10 mRNA CTD PMID:21346803 2,6-dichloroindophenol multiple interactions ISO RGD:1352024 6480464 [2, 6-Dichloroindophenol co-treated with NQO1 protein polymorphism] results in increased expression of CXCL10 mRNA CTD PMID:21034357 2-acetamidofluorene affects expression EXP 6480464 2-Acetylaminofluorene affects the expression of CXCL10 protein CTD PMID:25051504 2-amino-2-deoxy-D-glucopyranose multiple interactions ISO RGD:1550709 6480464 Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:20737476 2-amino-2-deoxy-D-glucopyranose multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL10 mRNA] CTD PMID:17109745 2-butan-2-yl-4-[4-[4-[4-[[2-(2,4-dichlorophenyl)-2-(1,2,4-triazol-1-ylmethyl)-1,3-dioxolan-4-yl]methoxy]phenyl]-1-piperazinyl]phenyl]-1,2,4-triazol-3-one multiple interactions ISO RGD:1352024 6480464 Itraconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA], Itraconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] CTD PMID:24471457 2-nitrofluorene increases expression EXP 6480464 2-nitrofluorene results in increased expression of CXCL10 mRNA CTD PMID:14600272 , PMID:15890375 3,3',4,4',5-pentachlorobiphenyl decreases expression ISO RGD:1352024 6480464 3 more ... CTD PMID:23146750 3,3',4,4',5-pentachlorobiphenyl increases expression ISO RGD:1352024 6480464 3 more ... CTD PMID:28351761 3-isobutyl-1-methyl-7H-xanthine multiple interactions ISO RGD:1550709 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL10 mRNA, TNF protein inhibits the reaction [[Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL10 mRNA] CTD PMID:23503329 3-methylcholanthrene multiple interactions ISO RGD:1550709 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL10 mRNA CTD PMID:23519560 3-Nitrofluoranthene increases expression ISO RGD:1352024 6480464 3-nitrofluoranthene results in increased expression of CXCL10 mRNA CTD PMID:19879285 3-phenylprop-2-enal multiple interactions ISO RGD:1550709 6480464 NFE2L2 protein inhibits the reaction [cinnamaldehyde results in increased expression of CXCL10 mRNA] CTD PMID:28219650 3-phenylprop-2-enal increases expression ISO RGD:1550709 6480464 cinnamaldehyde results in increased expression of CXCL10 mRNA CTD PMID:28219650 4,4'-diaminodiphenylmethane increases expression EXP 6480464 4, 4'-diaminodiphenylmethane results in increased expression of CXCL10 mRNA CTD PMID:25380136 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression EXP 6480464 Oxazolone results in increased expression of CXCL10 mRNA CTD PMID:21893156 4-(ethoxymethylene)-2-phenyloxazol-5-one decreases expression ISO RGD:1550709 6480464 Oxazolone results in decreased expression of CXCL10 mRNA CTD PMID:23445166 4-(ethoxymethylene)-2-phenyloxazol-5-one increases expression ISO RGD:1550709 6480464 Oxazolone results in increased expression of CXCL10 mRNA CTD PMID:19647056 , PMID:21404309 4-(N-nitrosomethylamino)-1-(3-pyridyl)butan-1-one increases expression EXP 6480464 4-(N-methyl-N-nitrosamino)-1-(3-pyridyl)-1-butanone results in increased expression of CXCL10 mRNA CTD PMID:14600272 , PMID:15890375 4-hydroxynon-2-enal multiple interactions ISO RGD:1550709 6480464 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA], 4-hydroxy-2-nonenal inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein] CTD PMID:19627980 4-hydroxyphenyl retinamide increases expression ISO RGD:1550709 6480464 Fenretinide results in increased expression of CXCL10 mRNA CTD PMID:28973697 4-nitroquinoline N-oxide decreases expression ISO RGD:1550709 6480464 4-Nitroquinoline-1-oxide results in decreased expression of CXCL10 mRNA CTD PMID:22561872 4-nitroquinoline N-oxide increases expression ISO RGD:1550709 6480464 4-Nitroquinoline-1-oxide results in increased expression of CXCL10 mRNA CTD PMID:22561872 5-aza-2'-deoxycytidine affects methylation ISO RGD:1352024 6480464 Decitabine affects the methylation of CXCL10 promoter CTD PMID:17488656 7,12-dimethyltetraphene multiple interactions ISO RGD:1550709 6480464 [9 more ... CTD PMID:27891153 , PMID:32553695 7,12-dimethyltetraphene increases expression ISO RGD:1550709 6480464 9 more ... CTD PMID:32553695 7-ketocholesterol increases expression ISO RGD:1352024 6480464 7-ketocholesterol results in increased expression of CXCL10 protein CTD PMID:24895526 8-Br-cAMP increases expression ISO RGD:1352024 6480464 8-Bromo Cyclic Adenosine Monophosphate results in increased expression of CXCL10 mRNA CTD PMID:22079614 acetamide increases expression EXP 6480464 acetamide results in increased expression of CXCL10 mRNA CTD PMID:31881176 acrolein multiple interactions ISO RGD:1550709 6480464 CD8A gene mutant form inhibits the reaction [Acrolein results in increased expression of CXCL10 mRNA] CTD PMID:17950725 acrolein increases expression ISO RGD:1550709 6480464 Acrolein results in increased expression of CXCL10 mRNA CTD PMID:17950725 acteoside decreases secretion ISO RGD:1352024 6480464 acteoside results in decreased secretion of CXCL10 protein CTD PMID:21756928 , PMID:21967610 acteoside decreases expression ISO RGD:1352024 6480464 acteoside results in decreased expression of CXCL10 mRNA CTD PMID:21756928 , PMID:21967610 acteoside multiple interactions ISO RGD:1352024 6480464 acteoside inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] more ... CTD PMID:21756928 , PMID:21967610 aflatoxin B1 affects expression ISO RGD:1352024 6480464 Aflatoxin B1 affects the expression of CXCL10 protein CTD PMID:20106945 aflatoxin B1 decreases expression ISO RGD:1352024 6480464 Aflatoxin B1 results in decreased expression of CXCL10 mRNA CTD PMID:27153756 aflatoxin B1 increases expression EXP 6480464 Aflatoxin B1 results in increased expression of CXCL10 mRNA CTD PMID:15890375 , PMID:25378103 aldehydo-D-glucosamine multiple interactions ISO RGD:1550709 6480464 Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:20737476 aldehydo-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL10 mRNA] CTD PMID:17109745 aldehydo-D-glucose increases expression ISO RGD:1550709 6480464 Glucose results in increased expression of CXCL10 mRNA CTD PMID:17178593 all-trans-retinoic acid decreases expression ISO RGD:1550709 6480464 Tretinoin results in decreased expression of CXCL10 mRNA CTD PMID:16604517 allopurinol multiple interactions ISO RGD:1352024 6480464 Allopurinol inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA] CTD PMID:18322232 alloxanthine increases expression ISO RGD:1352024 6480464 Oxypurinol results in increased expression of CXCL10 mRNA CTD PMID:25091725 aluminium hydroxide multiple interactions ISO RGD:1352024 6480464 [Aluminum Hydroxide co-treated with Magnesium Hydroxide] inhibits the reaction [K-12 lipopolysaccharide results in increased secretion of CXCL10 protein] CTD PMID:17404311 ammonium chloride affects expression EXP 6480464 Ammonium Chloride affects the expression of CXCL10 mRNA CTD PMID:16483693 amorolfine multiple interactions ISO RGD:1352024 6480464 amorolfine inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA], amorolfine inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] CTD PMID:24471457 amoxicillin decreases expression ISO RGD:1352024 6480464 Amoxicillin results in decreased expression of CXCL10 mRNA CTD PMID:25091725 amphetamine decreases expression EXP 6480464 Amphetamine results in decreased expression of CXCL10 mRNA CTD PMID:30779732 amphibole asbestos increases expression ISO RGD:1352024 6480464 Asbestos, Amphibole results in increased expression of CXCL10 protein CTD PMID:20855422 anthra[1,9-cd]pyrazol-6(2H)-one multiple interactions ISO RGD:1352024 6480464 pyrazolanthrone inhibits the reaction [IL1A protein results in increased expression of CXCL10 mRNA] CTD PMID:12832416 apocynin multiple interactions ISO RGD:1352024 6480464 acetovanillone inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA], acetovanillone inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA] CTD PMID:18322232 , PMID:22414048 arsenous acid increases expression ISO RGD:1352024 6480464 Arsenic Trioxide results in increased expression of CXCL10 mRNA CTD PMID:17530438 arsenous acid decreases expression ISO RGD:1352024 6480464 Arsenic Trioxide results in decreased expression of CXCL10 mRNA CTD PMID:27829220 asperentin increases expression ISO RGD:1550709 6480464 cladosporin results in increased expression of CXCL10 protein CTD PMID:21356202 asperentin decreases expression ISO RGD:1550709 6480464 cladosporin results in decreased expression of CXCL10 mRNA CTD PMID:19818335 atorvastatin calcium decreases expression EXP 6480464 Atorvastatin results in decreased expression of CXCL10 CTD PMID:15831368 Aurin decreases expression ISO RGD:1352024 6480464 aurin results in decreased expression of CXCL10 mRNA CTD PMID:25477506 bafilomycin A1 multiple interactions ISO RGD:1352024 6480464 bafilomycin A1 inhibits the reaction [CpG ODN 2216 results in increased expression of CXCL10 protein] more ... CTD PMID:26682054 bazedoxifene multiple interactions ISO RGD:1550709 6480464 bazedoxifene inhibits the reaction [lipopolysaccharide more ... CTD PMID:19533603 beclomethasone decreases secretion ISO RGD:1352024 6480464 Beclomethasone results in decreased secretion of CXCL10 protein CTD PMID:17996064 benzalkonium chloride increases expression ISO RGD:1550709 6480464 Benzalkonium Compounds results in increased expression of CXCL10 mRNA, Benzalkonium Compounds results in increased expression of CXCL10 protein CTD PMID:23445166 , PMID:30517752 benzalkonium chloride multiple interactions ISO RGD:1550709 6480464 [IL6RA gene mutant form results in increased susceptibility to Benzalkonium Compounds] which results in increased expression of CXCL10 protein CTD PMID:31158415 benzo[a]pyrene increases expression ISO RGD:1352024 6480464 Benzo(a)pyrene results in increased expression of CXCL10 mRNA CTD PMID:19152381 more ... benzo[a]pyrene decreases expression ISO RGD:1550709 6480464 Benzo(a)pyrene metabolite results in decreased expression of CXCL10 mRNA CTD PMID:32553695 benzo[a]pyrene increases methylation ISO RGD:1352024 6480464 Benzo(a)pyrene results in increased methylation of CXCL10 3' UTR CTD PMID:27901495 benzo[a]pyrene increases expression ISO RGD:1550709 6480464 Benzo(a)pyrene results in increased expression of CXCL10 mRNA CTD PMID:23735875 benzo[a]pyrene multiple interactions ISO RGD:1550709 6480464 [Benzo(a)pyrene results in increased activity of AHR protein] which results in decreased expression of CXCL10 mRNA, AHR protein affects the reaction [Benzo(a)pyrene affects the expression of CXCL10 mRNA] CTD PMID:22228805 , PMID:32553695 benzo[a]pyrene increases expression EXP 6480464 Benzo(a)pyrene results in increased expression of CXCL10 mRNA CTD PMID:21839799 benzo[a]pyrene multiple interactions ISO RGD:1352024 6480464 chlorophyllin inhibits the reaction [Benzo(a)pyrene results in increased expression of CXCL10 mRNA] CTD PMID:19152381 benzo[b]fluoranthene increases expression ISO RGD:1550709 6480464 benzo(b)fluoranthene results in increased expression of CXCL10 mRNA CTD PMID:26377693 benzoates increases expression ISO RGD:1352024 6480464 Benzoates analog results in increased expression of CXCL10 mRNA CTD PMID:29472718 beta-D-glucosamine multiple interactions ISO RGD:1550709 6480464 Glucosamine inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:20737476 beta-D-glucosamine multiple interactions EXP 6480464 Glucosamine inhibits the reaction [IL1B results in increased expression of CXCL10 mRNA] CTD PMID:17109745 beta-naphthoflavone decreases expression ISO RGD:1352024 6480464 beta-Naphthoflavone results in decreased expression of CXCL10 mRNA CTD PMID:32858204 bilirubin IXalpha increases expression ISO RGD:1352024 6480464 Bilirubin results in increased expression of CXCL10 mRNA CTD PMID:20196124 bis(2-chloroethyl) sulfide increases secretion ISO RGD:1352024 6480464 Mustard Gas results in increased secretion of CXCL10 protein CTD PMID:33491125 bis(2-chloroethyl) sulfide increases expression ISO RGD:1550709 6480464 Mustard Gas results in increased expression of CXCL10 mRNA, Mustard Gas results in increased expression of CXCL10 protein CTD PMID:29935281 bisphenol A increases expression EXP 6480464 bisphenol A results in increased expression of CXCL10 mRNA CTD PMID:17010207 , PMID:18180321 bisphenol A multiple interactions ISO RGD:1352024 6480464 [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CXCL10 mRNA CTD PMID:30398665 bisphenol A decreases secretion ISO RGD:1352024 6480464 bisphenol A results in decreased secretion of CXCL10 protein CTD PMID:27745655 bisphenol A affects expression EXP 6480464 bisphenol A affects the expression of CXCL10 mRNA CTD PMID:25181051 bleomycin A2 multiple interactions EXP 6480464 [Bleomycin co-treated with Tobacco Smoke Pollution] results in increased expression of CXCL10 protein CTD PMID:33516805 bleomycin A2 decreases expression ISO RGD:1550709 6480464 Bleomycin results in decreased expression of CXCL10 mRNA CTD PMID:29720568 bleomycin A2 increases expression ISO RGD:1550709 6480464 Bleomycin results in increased expression of CXCL10 mRNA CTD PMID:26345256 butanal increases expression ISO RGD:1352024 6480464 butyraldehyde results in increased expression of CXCL10 mRNA CTD PMID:26079696 butenafine multiple interactions ISO RGD:1352024 6480464 4-(5H-dibenzo(a more ... CTD PMID:24471457 cadmium dichloride decreases methylation EXP 6480464 Cadmium Chloride results in decreased methylation of CXCL10 promoter CTD PMID:22457795 cadmium dichloride increases expression EXP 6480464 Cadmium Chloride results in increased expression of CXCL10 mRNA CTD PMID:25993096 cadmium dichloride decreases expression EXP 6480464 Cadmium Chloride results in decreased expression of CXCL10 mRNA CTD PMID:33453195 calcium atom multiple interactions ISO RGD:1352024 6480464 [CTSS protein results in increased cleavage of and results in decreased activity of CXCL10 protein] which results in decreased uptake of Calcium, [CXCL10 protein binds to and results in increased activity of CXCR3 protein] which results in increased uptake of Calcium CTD PMID:25833952 calcium phosphate increases expression ISO RGD:1352024 6480464 calcium phosphate results in increased expression of CXCL10 protein CTD PMID:14600836 calcium(0) multiple interactions ISO RGD:1352024 6480464 [CTSS protein results in increased cleavage of and results in decreased activity of CXCL10 protein] which results in decreased uptake of Calcium, [CXCL10 protein binds to and results in increased activity of CXCR3 protein] which results in increased uptake of Calcium CTD PMID:25833952 cannabidiol multiple interactions ISO RGD:1352024 6480464 [Dronabinol co-treated with Cannabidiol] inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] more ... CTD PMID:31250491 , PMID:32244040 capsaicin increases expression EXP 6480464 Capsaicin results in increased expression of CXCL10 protein CTD PMID:22150557 capsaicin multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein] more ... CTD PMID:22150557 carbon nanotube decreases expression ISO RGD:1550709 6480464 Nanotubes more ... CTD PMID:25620056 carbon nanotube increases secretion ISO RGD:1352024 6480464 Nanotubes, Carbon results in increased secretion of CXCL10 protein CTD PMID:29348435 carbon nanotube affects expression ISO RGD:1550709 6480464 Nanotubes, Carbon affects the expression of CXCL10 mRNA CTD PMID:23845593 carbon nanotube increases expression ISO RGD:1352024 6480464 Nanotubes, Carbon results in increased expression of CXCL10 mRNA CTD PMID:26683310 , PMID:29348435 carbon nanotube multiple interactions ISO RGD:1550709 6480464 [PTGS2 gene mutant form results in increased susceptibility to [Nanotubes, Carbon co-treated with OVAL protein]] which results in increased expression of CXCL10 mRNA CTD PMID:23642096 carbon nanotube increases expression ISO RGD:1550709 6480464 Nanotubes more ... CTD PMID:25554681 cefaloridine increases expression EXP 6480464 Cephaloridine results in increased expression of CXCL10 mRNA CTD PMID:18500788 celastrol increases expression ISO RGD:1352024 6480464 celastrol results in increased expression of CXCL10 mRNA CTD PMID:25477506 celastrol multiple interactions ISO RGD:1550709 6480464 celastrol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:31901889 ceric oxide multiple interactions ISO RGD:1550709 6480464 ceric oxide inhibits the reaction [Antigens, Dermatophagoides results in increased expression of CXCL10 mRNA] CTD PMID:29792201 chenodeoxycholic acid increases expression ISO RGD:1550709 6480464 Chenodeoxycholic Acid results in increased expression of CXCL10 mRNA CTD PMID:21224055 chloroethene multiple interactions ISO RGD:1550709 6480464 [Dietary Fats co-treated with Vinyl Chloride] results in increased secretion of CXCL10 protein CTD PMID:31774537 chloroquine multiple interactions ISO RGD:1352024 6480464 Chloroquine inhibits the reaction [CpG ODN 2216 results in increased expression of CXCL10 protein] more ... CTD PMID:26682054 chondroitin sulfate multiple interactions ISO RGD:1352024 6480464 Chondroitin Sulfates inhibits the reaction [CTSB protein results in increased degradation of CXCL10 protein] more ... CTD PMID:25833952 chrysin multiple interactions ISO RGD:1550709 6480464 chrysin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA], chrysin inhibits the reaction [Poly I-C results in increased expression of CXCL10 mRNA] CTD PMID:19426678 ciguatoxin CTX1B affects expression ISO RGD:1550709 6480464 Ciguatoxins affects the expression of CXCL10 mRNA CTD PMID:18353800 cisplatin affects expression EXP 6480464 Cisplatin affects the expression of CXCL10 protein CTD PMID:25051504 cisplatin multiple interactions ISO RGD:1550709 6480464 [Cisplatin co-treated with TNF protein] results in increased expression of CXCL10 mRNA CTD PMID:23103562 cisplatin increases expression EXP 6480464 Cisplatin results in increased expression of CXCL10 mRNA CTD PMID:22023808 cisplatin increases expression ISO RGD:1550709 6480464 Cisplatin results in increased expression of CXCL10 mRNA CTD PMID:15814532 cobalt atom multiple interactions ISO RGD:1550709 6480464 [Organometallic Compounds co-treated with Cobalt] results in increased expression of CXCL10 mRNA more ... CTD PMID:22147119 , PMID:23503329 cobalt atom increases expression ISO RGD:1550709 6480464 Cobalt results in increased expression of CXCL10 mRNA CTD PMID:22147119 cobalt dichloride increases secretion ISO RGD:1352024 6480464 cobaltous chloride results in increased secretion of CXCL10 protein CTD PMID:25183586 cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of CXCL10 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1352024 6480464 cobaltous chloride results in increased expression of CXCL10 mRNA CTD PMID:25183586 cobalt dichloride multiple interactions ISO RGD:1352024 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [cobaltous chloride results in increased secretion of CXCL10 protein] CTD PMID:25183586 cocaine increases secretion ISO RGD:1352024 6480464 Cocaine results in increased secretion of CXCL10 protein CTD PMID:10065903 copper(II) sulfate decreases expression ISO RGD:1352024 6480464 Copper Sulfate results in decreased expression of CXCL10 mRNA CTD PMID:19549813 crocidolite asbestos increases expression ISO RGD:1352024 6480464 Asbestos, Crocidolite results in increased expression of CXCL10 mRNA CTD PMID:25351596 crocidolite asbestos increases expression ISO RGD:1550709 6480464 Asbestos more ... CTD PMID:26119930 , PMID:29507420 Cuprizon increases expression EXP 6480464 Cuprizone results in increased expression of CXCL10 mRNA CTD PMID:27523638 cycloheximide multiple interactions ISO RGD:1352024 6480464 Cycloheximide inhibits the reaction [TNF protein results in increased expression of CXCL10 protein], Cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CXCL10 protein]] CTD PMID:22121136 cyclophosphamide affects expression ISO RGD:1550709 6480464 Cyclophosphamide affects the expression of CXCL10 mRNA CTD PMID:18957084 cyclophosphamide increases expression ISO RGD:1550709 6480464 Cyclophosphamide results in increased expression of CXCL10 protein CTD PMID:18957084 cyclophosphamide increases response to substance ISO RGD:1550709 6480464 CXCL10 protein results in increased susceptibility to Cyclophosphamide CTD PMID:18957084 cyclosporin A decreases expression ISO RGD:1352024 6480464 Cyclosporine results in decreased expression of CXCL10 mRNA CTD PMID:20106945 , PMID:27989131 cyclosporin A multiple interactions ISO RGD:1550709 6480464 ethyl 6-(N-(2-chloro-4-fluorophenyl)sulfamoyl)cyclohex-1-ene-1-carboxylate inhibits the reaction [Cyclosporine results in increased expression of CXCL10 mRNA], TLR4 gene mutant form inhibits the reaction [Cyclosporine results in increased expression of CXCL10 mRNA] CTD PMID:27585667 cyclosporin A increases expression ISO RGD:1550709 6480464 Cyclosporine results in increased expression of CXCL10 mRNA CTD PMID:19770486 more ... cyclosporin A increases expression EXP 6480464 Cyclosporine results in increased expression of CXCL10 mRNA CTD PMID:21865292 D-glucose increases expression ISO RGD:1550709 6480464 Glucose results in increased expression of CXCL10 mRNA CTD PMID:17178593 deoxycholic acid increases expression ISO RGD:1550709 6480464 Deoxycholic Acid results in increased expression of CXCL10 mRNA CTD PMID:21224055 deoxynivalenol increases expression ISO RGD:1550709 6480464 deoxynivalenol results in increased expression of CXCL10 mRNA CTD PMID:15371230 deoxynivalenol decreases expression ISO RGD:1550709 6480464 deoxynivalenol results in decreased expression of CXCL10 mRNA CTD PMID:22968694 dexamethasone increases expression ISO RGD:1550709 6480464 Dexamethasone results in increased expression of CXCL10 mRNA CTD PMID:21041162 dexamethasone multiple interactions ISO RGD:1352024 6480464 Dexamethasone inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein] CTD PMID:27568862 dexamethasone multiple interactions ISO RGD:1550709 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL10 mRNA more ... CTD PMID:23503329 , PMID:27568862 dextran sulfate multiple interactions ISO RGD:1550709 6480464 [Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL10 mRNA, isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL10 mRNA] CTD PMID:25026504 diarsenic trioxide increases expression ISO RGD:1352024 6480464 Arsenic Trioxide results in increased expression of CXCL10 mRNA CTD PMID:17530438 diarsenic trioxide decreases expression ISO RGD:1352024 6480464 Arsenic Trioxide results in decreased expression of CXCL10 mRNA CTD PMID:27829220 dibutyl phthalate increases expression EXP 6480464 Dibutyl Phthalate results in increased expression of CXCL10 mRNA CTD PMID:21266533 dibutyl phthalate increases expression ISO RGD:1550709 6480464 Dibutyl Phthalate results in increased expression of CXCL10 mRNA CTD PMID:17361019 , PMID:21266533 dichlorine decreases expression EXP 6480464 Chlorine results in decreased expression of CXCL10 mRNA CTD PMID:18636392 dichlorine multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of CXCL10 mRNA CTD PMID:18636392 diethyl maleate decreases expression EXP 6480464 diethyl maleate results in decreased expression of CXCL10 mRNA CTD PMID:21161181 diethylstilbestrol increases expression EXP 6480464 Diethylstilbestrol results in increased expression of CXCL10 mRNA CTD PMID:15890375 diethylstilbestrol decreases expression EXP 6480464 Diethylstilbestrol results in decreased expression of CXCL10 mRNA CTD PMID:21658437 dimethoate increases expression ISO RGD:1550709 6480464 Dimethoate results in increased expression of CXCL10 mRNA CTD PMID:23943137 dimethoate multiple interactions ISO RGD:1550709 6480464 Estradiol inhibits the reaction [Dimethoate results in increased expression of CXCL10 mRNA], fulvestrant inhibits the reaction [Estradiol inhibits the reaction [Dimethoate results in increased expression of CXCL10 mRNA]] CTD PMID:23943137 dioxygen multiple interactions ISO RGD:1352024 6480464 Oxygen affects the reaction [AHR protein results in increased expression of CXCL10 mRNA] CTD PMID:27103661 dioxygen multiple interactions ISO RGD:1550709 6480464 [NFE2L2 protein affects the susceptibility to Oxygen] which affects the expression of CXCL10 mRNA CTD PMID:30529165 divanadium pentaoxide multiple interactions ISO RGD:1352024 6480464 acetovanillone inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA], Allopurinol inhibits the reaction [vanadium pentoxide results in increased expression of CXCL10 mRNA] CTD PMID:18322232 divanadium pentaoxide increases expression ISO RGD:1352024 6480464 vanadium pentoxide results in increased expression of CXCL10 mRNA CTD PMID:17459161 , PMID:18322232 doramapimod decreases secretion ISO RGD:1352024 6480464 BIRB 796 results in decreased secretion of CXCL10 protein CTD PMID:17996064 doxorubicin increases expression EXP 6480464 Doxorubicin results in increased expression of CXCL10 mRNA CTD PMID:27181935 doxorubicin multiple interactions ISO RGD:1352024 6480464 Doxorubicin results in decreased expression of and results in decreased secretion of CXCL10 protein CTD PMID:29959987 doxorubicin decreases expression ISO RGD:1352024 6480464 Doxorubicin results in decreased expression of CXCL10 mRNA CTD PMID:29803840 doxorubicin multiple interactions EXP 6480464 Fungal Polysaccharides inhibits the reaction [Doxorubicin results in increased expression of CXCL10 mRNA] CTD PMID:27181935 endosulfan increases expression EXP 6480464 Endosulfan results in increased expression of CXCL10 mRNA CTD PMID:29391264 entinostat increases expression ISO RGD:1352024 6480464 entinostat results in increased expression of CXCL10 mRNA CTD PMID:27188386 eriodictyol multiple interactions ISO RGD:1550709 6480464 eriodictyol inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA], eriodictyol inhibits the reaction [Poly I-C results in increased expression of CXCL10 mRNA] CTD PMID:19426678 ethanol multiple interactions ISO RGD:1550709 6480464 [Zinc deficiency co-treated with Ethanol] results in increased expression of CXCL10 mRNA more ... CTD PMID:20861358 more ... ethanol increases expression ISO RGD:1550709 6480464 Ethanol results in increased expression of CXCL10 mRNA CTD PMID:24946281 ethanol multiple interactions EXP 6480464 ADIPOQ protein inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]], Ethanol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:20861358 ethionamide decreases expression EXP 6480464 Ethionamide results in decreased expression of CXCL10 protein CTD PMID:25051504 ethylene glycol bis(2-aminoethyl)tetraacetic acid multiple interactions ISO RGD:1352024 6480464 Egtazic Acid inhibits the reaction [Vehicle Emissions results in increased secretion of CXCL10 protein] CTD PMID:21245013 fluoranthene multiple interactions ISO RGD:1550709 6480464 [1-methylanthracene co-treated with fluoranthene] results in increased expression of CXCL10 mRNA CTD PMID:28329830 fluoxetine decreases secretion ISO RGD:1550709 6480464 Fluoxetine results in decreased secretion of CXCL10 protein CTD PMID:21083617 flutamide decreases expression EXP 6480464 Flutamide results in decreased expression of CXCL10 protein CTD PMID:25051504 folpet decreases expression ISO RGD:1550709 6480464 folpet results in decreased expression of CXCL10 mRNA CTD PMID:31558096 formaldehyde increases expression ISO RGD:1352024 6480464 Formaldehyde results in increased expression of CXCL10 mRNA CTD PMID:23649840 fragrance increases expression ISO RGD:1352024 6480464 Perfume results in increased expression of CXCL10 mRNA CTD PMID:24768652 fulvestrant multiple interactions ISO RGD:1550709 6480464 fulvestrant inhibits the reaction [bazedoxifene inhibits the reaction [lipopolysaccharide more ... CTD PMID:19533603 , PMID:23943137 fulvestrant multiple interactions ISO RGD:1352024 6480464 fulvestrant inhibits the reaction [Estradiol results in increased expression of CXCL10 mRNA] CTD PMID:15557169 furan decreases expression EXP 6480464 furan results in decreased expression of CXCL10 mRNA CTD PMID:15120968 furan increases expression ISO RGD:1550709 6480464 furan results in increased expression of CXCL10 mRNA CTD PMID:20194422 , PMID:24183702 gadodiamide hydrate increases expression ISO RGD:1352024 6480464 gadodiamide results in increased expression of CXCL10 mRNA CTD PMID:20959327 gadodiamide hydrate increases expression EXP 6480464 gadodiamide results in increased expression of CXCL10 protein CTD PMID:20938346 gadodiamide hydrate increases secretion ISO RGD:1352024 6480464 gadodiamide results in increased secretion of CXCL10 protein CTD PMID:20959327 gemfibrozil decreases expression EXP 6480464 Gemfibrozil results in decreased expression of CXCL10 protein CTD PMID:25051504 Genipin multiple interactions ISO RGD:1550709 6480464 genipin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:22687549 genistein increases expression EXP 6480464 Genistein results in increased expression of CXCL10 mRNA CTD PMID:17010207 genistein multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of CXCL10 mRNA CTD PMID:21782745 gentamycin increases expression EXP 6480464 Gentamicins results in increased expression of CXCL10 mRNA CTD PMID:22061828 , PMID:33387578 gentamycin decreases expression EXP 6480464 Gentamicins results in decreased expression of CXCL10 protein CTD PMID:25051504 glucose increases expression ISO RGD:1550709 6480464 Glucose results in increased expression of CXCL10 mRNA CTD PMID:17178593 gold atom increases secretion ISO RGD:1550709 6480464 Gold results in increased secretion of CXCL10 protein CTD PMID:22155353 gold atom multiple interactions ISO RGD:1550709 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein CTD PMID:22155353 gold(0) increases secretion ISO RGD:1550709 6480464 Gold results in increased secretion of CXCL10 protein CTD PMID:22155353 gold(0) multiple interactions ISO RGD:1550709 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein CTD PMID:22155353 graphene oxide increases expression ISO RGD:1550709 6480464 graphene oxide results in increased expression of CXCL10 mRNA CTD PMID:33227293 halothane decreases expression EXP 6480464 Halothane results in decreased expression of CXCL10 mRNA CTD PMID:15564938 heparan sulfate multiple interactions ISO RGD:1352024 6480464 CXCL10 protein inhibits the reaction [CXCL1 protein binds to Heparitin Sulfate] CTD PMID:12549928 heparin multiple interactions EXP 6480464 Heparin inhibits the reaction [endotoxin, Escherichia coli results in increased expression of CXCL10 mRNA] CTD PMID:31813902 hexachlorobenzene affects expression EXP 6480464 Hexachlorobenzene affects the expression of CXCL10 mRNA CTD PMID:15159207 hexadecanoic acid multiple interactions ISO RGD:1352024 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of CXCL10 mRNA CTD PMID:30547786 hydrazine multiple interactions ISO RGD:1550709 6480464 hydrazine inhibits the reaction [2-chloroethyl ethyl sulfide results in increased expression of CXCL10 mRNA] CTD PMID:32142722 hydroxychloroquine increases expression ISO RGD:1352024 6480464 Hydroxychloroquine results in increased expression of CXCL10 mRNA CTD PMID:25321315 ibuprofen multiple interactions ISO RGD:1352024 6480464 Ibuprofen inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 protein] CTD PMID:19020770 imiquimod multiple interactions ISO RGD:1352024 6480464 [Pam(3)CSK(4) peptide co-treated with Antigens more ... CTD PMID:28655636 immunological adjuvant multiple interactions ISO RGD:1352024 6480464 Adjuvants, Immunologic inhibits the reaction [K-12 lipopolysaccharide results in increased secretion of CXCL10 protein] CTD PMID:17404311 immunological adjuvant multiple interactions ISO RGD:1550709 6480464 Adjuvants more ... CTD PMID:17404311 indometacin multiple interactions ISO RGD:1352024 6480464 Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]]], Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]] CTD PMID:21913898 iron(2+) sulfate (anhydrous) increases expression ISO RGD:1352024 6480464 ferrous sulfate results in increased expression of CXCL10 mRNA CTD PMID:19428942 isoflurane decreases expression EXP 6480464 Isoflurane results in decreased expression of CXCL10 mRNA CTD PMID:15564938 isoliquiritigenin multiple interactions ISO RGD:1550709 6480464 isoliquiritigenin inhibits the reaction [[Azoxymethane co-treated with Dextran Sulfate] results in decreased expression of CXCL10 mRNA] CTD PMID:25026504 isoniazide increases secretion ISO RGD:1352024 6480464 Isoniazid results in increased secretion of CXCL10 protein CTD PMID:28444390 isotretinoin decreases expression ISO RGD:1352024 6480464 Isotretinoin results in decreased expression of CXCL10 mRNA CTD PMID:15972972 isotretinoin decreases expression EXP 6480464 Isotretinoin results in decreased expression of CXCL10 mRNA CTD PMID:15972972 itraconazole multiple interactions ISO RGD:1352024 6480464 Itraconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA], Itraconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] CTD PMID:24471457 ketoconazole multiple interactions ISO RGD:1352024 6480464 Ketoconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA], Ketoconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] CTD PMID:24471457 L-ascorbic acid decreases expression ISO RGD:1352024 6480464 Ascorbic Acid results in decreased expression of CXCL10 mRNA CTD PMID:19932582 L-ascorbic acid increases expression ISO RGD:1352024 6480464 Ascorbic Acid deficiency results in increased expression of CXCL10 mRNA CTD PMID:19932582 leptomycin B decreases secretion ISO RGD:1352024 6480464 leptomycin B results in decreased secretion of CXCL10 protein CTD PMID:21967610 leptomycin B multiple interactions ISO RGD:1352024 6480464 acteoside promotes the reaction [leptomycin B results in decreased secretion of CXCL10 protein], Quercetin promotes the reaction [leptomycin B results in decreased secretion of CXCL10 protein] CTD PMID:21967610 levonorgestrel multiple interactions ISO RGD:1352024 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CXCL10 mRNA CTD PMID:19074003 linuron multiple interactions ISO RGD:1550709 6480464 SIGMAR1 gene mutant form inhibits the reaction [Linuron results in increased expression of CXCL10 mRNA] CTD PMID:30661753 linuron increases expression ISO RGD:1550709 6480464 Linuron results in increased expression of CXCL10 mRNA CTD PMID:30661753 lipopolysaccharide increases secretion ISO RGD:1550709 6480464 Lipopolysaccharides results in increased secretion of CXCL10 protein CTD PMID:32800949 lipopolysaccharide increases expression ISO RGD:1550709 6480464 Lipopolysaccharides results in increased expression of CXCL10 mRNA, Lipopolysaccharides results in increased expression of CXCL10 protein CTD PMID:10027076 more ... lipopolysaccharide increases secretion ISO RGD:1352024 6480464 Lipopolysaccharides results in increased secretion of CXCL10 protein CTD PMID:21913898 , PMID:32800949 lipopolysaccharide increases expression EXP 6480464 Lipopolysaccharides results in increased expression of CXCL10 mRNA, Lipopolysaccharides results in increased expression of CXCL10 protein CTD PMID:20861358 more ... lipopolysaccharide multiple interactions ISO RGD:1550709 6480464 (+)-JQ1 compound inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] more ... CTD PMID:11123339 more ... lipopolysaccharide multiple interactions EXP 6480464 ADIPOQ protein inhibits the reaction [Ethanol promotes the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]] more ... CTD PMID:20861358 lipopolysaccharide increases expression ISO RGD:1352024 6480464 Lipopolysaccharides results in increased expression of CXCL10 mRNA, Lipopolysaccharides results in increased expression of CXCL10 protein CTD PMID:15860229 more ... lipopolysaccharide multiple interactions ISO RGD:1352024 6480464 [Dronabinol co-treated with Cannabidiol] inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] more ... CTD PMID:19020770 more ... lucanthone increases expression ISO RGD:1352024 6480464 Lucanthone results in increased expression of CXCL10 mRNA CTD PMID:21148553 Luliconazole multiple interactions ISO RGD:1352024 6480464 luliconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA], luliconazole inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] CTD PMID:24471457 luteolin multiple interactions ISO RGD:1550709 6480464 Luteolin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA], Luteolin inhibits the reaction [Poly I-C results in increased expression of CXCL10 mRNA] CTD PMID:19426678 LY294002 multiple interactions ISO RGD:1550709 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltiprotoporphyrin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]] CTD PMID:25171655 magnesium dihydroxide multiple interactions ISO RGD:1352024 6480464 [Aluminum Hydroxide co-treated with Magnesium Hydroxide] inhibits the reaction [K-12 lipopolysaccharide results in increased secretion of CXCL10 protein] CTD PMID:17404311 manganese(II) chloride increases expression ISO RGD:1352024 6480464 manganese chloride results in increased expression of CXCL10 mRNA CTD PMID:27427241 melatonin multiple interactions ISO RGD:1550709 6480464 [Lipopolysaccharides co-treated with Melatonin] results in decreased expression of CXCL10 mRNA, Melatonin inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:21461237 melatonin decreases expression ISO RGD:1550709 6480464 Melatonin results in decreased expression of CXCL10 mRNA CTD PMID:21461237 mercury dichloride increases response to substance EXP 6480464 CXCL10 protein results in increased susceptibility to Mercuric Chloride CTD PMID:12834626 mercury dichloride increases expression EXP 6480464 Mercuric Chloride results in increased expression of CXCL10 mRNA CTD PMID:12834626 metacetamol decreases expression ISO RGD:1550709 6480464 3-hydroxyacetanilide results in decreased expression of CXCL10 mRNA CTD PMID:18544908 methamphetamine increases expression ISO RGD:1352024 6480464 Methamphetamine results in increased expression of CXCL10 mRNA CTD PMID:25290377 methapyrilene decreases expression EXP 6480464 Methapyrilene results in decreased expression of CXCL10 protein CTD PMID:25051504 methapyrilene increases expression EXP 6480464 Methapyrilene results in increased expression of CXCL10 mRNA CTD PMID:15890375 methotrexate affects expression ISO RGD:1550709 6480464 Methotrexate affects the expression of CXCL10 mRNA CTD PMID:18502557 methotrexate decreases expression EXP 6480464 Methotrexate results in decreased expression of CXCL10 mRNA CTD PMID:15120968 methoxychlor multiple interactions EXP 6480464 [Genistein co-treated with Methoxychlor] results in decreased expression of CXCL10 mRNA CTD PMID:21782745 methyl methanesulfonate decreases expression ISO RGD:1352024 6480464 Methyl Methanesulfonate results in decreased expression of CXCL10 mRNA CTD PMID:23649840 methylmercury chloride increases expression ISO RGD:1550709 6480464 methylmercuric chloride results in increased expression of CXCL10 mRNA CTD PMID:24213012 , PMID:30103553 methylmercury chloride multiple interactions ISO RGD:1550709 6480464 [MT3 protein affects the susceptibility to methylmercuric chloride] which affects the expression of CXCL10 mRNA, MT3 protein affects the reaction [methylmercuric chloride results in increased expression of CXCL10 mRNA] CTD PMID:30103553 methylmercury chloride increases expression EXP 6480464 methylmercuric chloride results in increased expression of CXCL10 mRNA, methylmercuric chloride results in increased expression of CXCL10 protein CTD PMID:28526320 , PMID:31378766 mono(2-ethylhexyl) phthalate increases expression EXP 6480464 mono-(2-ethylhexyl)phthalate results in increased expression of CXCL10 mRNA CTD PMID:16809437 mono(2-ethylhexyl) phthalate multiple interactions ISO RGD:1352024 6480464 [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CXCL10 mRNA CTD PMID:30398665 monobenzyl phthalate multiple interactions ISO RGD:1352024 6480464 [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CXCL10 mRNA CTD PMID:30398665 Monobutylphthalate multiple interactions ISO RGD:1352024 6480464 [bisphenol A co-treated with mono-(2-ethylhexyl)phthalate co-treated with mono-benzyl phthalate co-treated with monobutyl phthalate] results in increased expression of CXCL10 mRNA CTD PMID:30398665 monocrotaline decreases expression EXP 6480464 Monocrotaline results in decreased expression of CXCL10 protein CTD PMID:25051504 monocrotaline multiple interactions ISO RGD:1550709 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA CTD PMID:21224054 Muraglitazar decreases expression EXP 6480464 muraglitazar results in decreased expression of CXCL10 mRNA CTD PMID:21515302 mycotoxin increases expression ISO RGD:1550709 6480464 Mycotoxins results in increased expression of CXCL10 mRNA, Mycotoxins results in increased expression of CXCL10 protein CTD PMID:21356202 mycotoxin decreases expression ISO RGD:1550709 6480464 Mycotoxins results in decreased expression of CXCL10 mRNA CTD PMID:19818335 N,N-diethyl-m-toluamide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of CXCL10 protein CTD PMID:28659758 N-nitrosodiethylamine decreases expression EXP 6480464 Diethylnitrosamine results in decreased expression of CXCL10 protein CTD PMID:25051504 N-nitrosodiethylamine multiple interactions ISO RGD:1550709 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CXCL10 mRNA CTD PMID:24535843 N-nitrosodiethylamine increases expression EXP 6480464 Diethylnitrosamine results in increased expression of CXCL10 protein CTD PMID:25051504 N-nitrosodimethylamine increases expression EXP 6480464 Dimethylnitrosamine results in increased expression of CXCL10 mRNA CTD PMID:14600272 more ... N-nitrosomorpholine increases expression EXP 6480464 N-nitrosomorpholine results in increased expression of CXCL10 mRNA CTD PMID:19716841 naphthalene increases expression ISO RGD:1550709 6480464 naphthalene results in increased expression of CXCL10 mRNA CTD PMID:18978301 naproxen multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein], Naproxen inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein] CTD PMID:22150557 neoechinulin A decreases expression ISO RGD:1550709 6480464 neoechinulin A results in decreased expression of CXCL10 mRNA CTD PMID:19818335 neoechinulin A increases expression ISO RGD:1550709 6480464 neoechinulin A results in increased expression of CXCL10 protein CTD PMID:21356202 nickel atom multiple interactions EXP 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [PDGFB protein promotes the reaction [Nickel analog results in increased expression of CXCL10 mRNA]] more ... CTD PMID:22700867 nickel atom increases expression ISO RGD:1352024 6480464 Nickel results in increased expression of CXCL10 mRNA CTD PMID:24768652 , PMID:25583101 nickel atom multiple interactions ISO RGD:1550709 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL10 mRNA more ... CTD PMID:23503329 nickel atom increases expression EXP 6480464 Nickel analog results in increased expression of CXCL10 mRNA, Nickel analog results in increased expression of CXCL10 protein CTD PMID:22700867 nickel dichloride multiple interactions ISO RGD:1352024 6480464 nickel chloride inhibits the reaction [lipopolysaccharide, E. coli O26-B6 results in increased expression of CXCL10 mRNA] CTD PMID:23090859 nickel dichloride increases expression ISO RGD:1352024 6480464 nickel chloride results in increased expression of CXCL10 mRNA CTD PMID:27427241 nickel sulfate increases expression ISO RGD:1352024 6480464 nickel sulfate results in increased expression of CXCL10 mRNA CTD PMID:12060402 nickel sulfate decreases expression ISO RGD:1550709 6480464 nickel sulfate results in decreased expression of CXCL10 mRNA CTD PMID:23445166 nickel sulfate multiple interactions ISO RGD:1352024 6480464 [macrophage stimulatory lipopeptide 2 co-treated with nickel sulfate] results in increased expression of CXCL10 mRNA more ... CTD PMID:18096868 , PMID:18832182 nimesulide multiple interactions ISO RGD:1550709 6480464 [nimesulide results in decreased activity of PTGS2 protein] which results in increased expression of CXCL10 mRNA CTD PMID:22561872 nitric oxide decreases secretion ISO RGD:1352024 6480464 Nitric Oxide results in decreased secretion of CXCL10 protein CTD PMID:13678430 Nonylphenol increases expression EXP 6480464 nonylphenol results in increased expression of CXCL10 mRNA CTD PMID:17010207 NS-398 multiple interactions ISO RGD:1352024 6480464 N-(2-cyclohexyloxy-4-nitrophenyl)methanesulfonamide inhibits the reaction [nickel sulfate inhibits the reaction [macrophage stimulatory lipopeptide 2 results in increased secretion of CXCL10 protein]] CTD PMID:18096868 oleic acid multiple interactions ISO RGD:1352024 6480464 [Palmitic Acid co-treated with Oleic Acid] affects the expression of CXCL10 mRNA CTD PMID:30547786 ospemifene multiple interactions ISO RGD:1550709 6480464 Fulvestrant inhibits the reaction [Ospemifene inhibits the reaction [lipopolysaccharide more ... CTD PMID:19533603 oxaliplatin multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CXCL10 mRNA CTD PMID:25729387 oxaliplatin increases expression EXP 6480464 oxaliplatin results in increased expression of CXCL10 mRNA CTD PMID:25729387 ozone multiple interactions ISO RGD:1550709 6480464 [LEP gene mutant form results in increased susceptibility to Ozone] which results in increased expression of CXCL10 protein more ... CTD PMID:17575079 more ... ozone increases secretion ISO RGD:1550709 6480464 Ozone results in increased secretion of CXCL10 protein CTD PMID:31626304 ozone multiple interactions EXP 6480464 [Ozone co-treated with Chlorine] results in increased expression of CXCL10 mRNA CTD PMID:18636392 ozone increases response to substance ISO RGD:1550709 6480464 CXCL10 protein results in increased susceptibility to Ozone CTD PMID:11777981 ozone increases expression ISO RGD:1550709 6480464 Ozone results in increased expression of CXCL10 mRNA, Ozone results in increased expression of CXCL10 protein CTD PMID:11777981 more ... paclitaxel increases expression ISO RGD:1550709 6480464 Paclitaxel results in increased expression of CXCL10 mRNA CTD PMID:11123339 paclitaxel multiple interactions ISO RGD:1550709 6480464 TLR4 protein affects the reaction [Paclitaxel results in increased expression of CXCL10 mRNA] CTD PMID:11123339 paracetamol increases expression EXP 6480464 Acetaminophen results in increased expression of CXCL10 mRNA CTD PMID:33387578 paracetamol decreases expression ISO RGD:1352024 6480464 Acetaminophen results in decreased expression of CXCL10 mRNA CTD PMID:21420995 , PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CXCL10 mRNA CTD PMID:15120968 paracetamol multiple interactions ISO RGD:1550709 6480464 IFNG protein promotes the reaction [Acetaminophen results in increased expression of CXCL10 mRNA], KLRB1C protein promotes the reaction [Acetaminophen results in increased expression of CXCL10 mRNA] CTD PMID:12153990 , PMID:15578514 paracetamol increases expression ISO RGD:1550709 6480464 [Acetaminophen results in increased expression of CXCL10 protein] which results in increased expression of CXCR2 protein more ... CTD PMID:11739529 more ... paracetamol affects expression ISO RGD:1550709 6480464 Acetaminophen affects the expression of CXCL10 mRNA CTD PMID:17562736 paraquat increases expression ISO RGD:1352024 6480464 Paraquat results in increased expression of CXCL10 mRNA CTD PMID:22230393 paraquat increases expression ISO RGD:1550709 6480464 Paraquat results in increased expression of CXCL10 mRNA CTD PMID:26345256 PD 168393 increases expression ISO RGD:1352024 6480464 PD168393 results in increased expression of CXCL10 mRNA CTD PMID:21967610 PD 168393 multiple interactions ISO RGD:1352024 6480464 acteoside inhibits the reaction [PD168393 results in increased secretion of CXCL10 protein] more ... CTD PMID:21967610 pentachlorophenol increases expression ISO RGD:1550709 6480464 Pentachlorophenol results in increased expression of CXCL10 mRNA CTD PMID:23892564 perfluorooctane-1-sulfonic acid decreases expression ISO RGD:1352024 6480464 perfluorooctane sulfonic acid results in decreased expression of CXCL10 mRNA CTD PMID:27153767 , PMID:32588087 perfluorooctanoic acid multiple interactions ISO RGD:1550709 6480464 Dietary Fats, Unsaturated promotes the reaction [perfluorooctanoic acid results in increased expression of CXCL10 mRNA] CTD PMID:23626681 perfluorooctanoic acid decreases expression ISO RGD:1352024 6480464 perfluorooctanoic acid results in decreased expression of CXCL10 mRNA CTD PMID:27153767 , PMID:32588087 permethrin multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of CXCL10 protein CTD PMID:28659758 phenethyl isothiocyanate multiple interactions ISO RGD:1550709 6480464 phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:20423518 phenethyl isothiocyanate multiple interactions ISO RGD:1352024 6480464 phenethyl isothiocyanate inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA] CTD PMID:23724058 phenformin decreases expression EXP 6480464 Phenformin results in decreased expression of CXCL10 mRNA CTD PMID:31324951 phenobarbital affects expression EXP 6480464 Phenobarbital affects the expression of CXCL10 protein CTD PMID:25051504 phenobarbital affects expression ISO RGD:1550709 6480464 Phenobarbital affects the expression of CXCL10 mRNA CTD PMID:23091169 phenobarbital increases expression ISO RGD:1550709 6480464 Phenobarbital results in increased expression of CXCL10 mRNA CTD PMID:19482888 phenobarbital multiple interactions ISO RGD:1550709 6480464 [Diethylnitrosamine co-treated with Phenobarbital] results in increased expression of CXCL10 mRNA, NR1I3 protein affects the reaction [Phenobarbital results in increased expression of CXCL10 mRNA] CTD PMID:19482888 , PMID:24535843 phenylephrine decreases expression EXP 6480464 Phenylephrine results in decreased expression of CXCL10 mRNA CTD PMID:18158353 phenytoin multiple interactions ISO RGD:1550709 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA CTD PMID:21224054 PhIP increases expression EXP 6480464 2-amino-1-methyl-6-phenylimidazo(4, 5-b)pyridine results in increased expression of CXCL10 mRNA CTD PMID:15059925 phorbol 13-acetate 12-myristate decreases expression ISO RGD:1550709 6480464 Tetradecanoylphorbol Acetate results in decreased expression of CXCL10 mRNA CTD PMID:22359662 phorbol 13-acetate 12-myristate multiple interactions ISO RGD:1550709 6480464 [Methylcholanthrene co-treated with Tetradecanoylphorbol Acetate] results in decreased expression of CXCL10 mRNA, IL17RA gene mutant form inhibits the reaction [Tetradecanoylphorbol Acetate results in decreased expression of CXCL10 mRNA] CTD PMID:22359662 , PMID:23519560 piperonyl butoxide increases expression EXP 6480464 Piperonyl Butoxide results in increased expression of CXCL10 mRNA CTD PMID:15890375 pirinixic acid increases expression EXP 6480464 pirinixic acid results in increased expression of CXCL10 mRNA CTD PMID:15890375 poly(I:C) increases expression ISO RGD:1550709 6480464 Poly I-C results in increased expression of CXCL10 mRNA CTD PMID:19426678 , PMID:25780039 poly(I:C) multiple interactions EXP 6480464 cyclohexyl carbamic acid 3'-carbamoylbiphenyl-3-yl ester inhibits the reaction [Poly I-C results in increased expression of CXCL10 mRNA] CTD PMID:28726298 poly(I:C) increases expression EXP 6480464 Poly I-C results in increased expression of CXCL10 mRNA CTD PMID:28726298 poly(I:C) increases expression ISO RGD:1352024 6480464 Poly I-C results in increased expression of CXCL10 mRNA, Poly I-C results in increased expression of CXCL10 protein CTD PMID:26682054 more ... poly(I:C) multiple interactions ISO RGD:1352024 6480464 [Dronabinol co-treated with Cannabidiol] inhibits the reaction [Poly I-C results in increased expression of CXCL10 protein] more ... CTD PMID:26682054 more ... poly(I:C) multiple interactions ISO RGD:1550709 6480464 APPL1 protein promotes the reaction [Poly I-C results in increased expression of CXCL10 mRNA] more ... CTD PMID:19426678 , PMID:25780039 potassium chromate decreases expression ISO RGD:1352024 6480464 potassium chromate(VI) results in decreased expression of CXCL10 mRNA CTD PMID:22079256 potassium chromate multiple interactions ISO RGD:1352024 6480464 [potassium chromate(VI) co-treated with epigallocatechin gallate] results in decreased expression of CXCL10 mRNA CTD PMID:22079256 potassium dichromate increases expression ISO RGD:1550709 6480464 Potassium Dichromate results in increased expression of CXCL10 mRNA CTD PMID:23608068 procymidone decreases expression EXP 6480464 procymidone results in decreased expression of CXCL10 mRNA CTD PMID:15686871 progesterone multiple interactions ISO RGD:1352024 6480464 [Progesterone co-treated with Estradiol] results in increased expression of CXCL10 mRNA CTD PMID:17404688 progesterone decreases expression ISO RGD:1550709 6480464 Progesterone results in decreased expression of CXCL10 mRNA, Progesterone results in decreased expression of CXCL10 protein CTD PMID:21549006 progesterone increases expression ISO RGD:1352024 6480464 Progesterone results in increased expression of CXCL10 mRNA CTD PMID:15557169 propanal increases expression ISO RGD:1352024 6480464 propionaldehyde results in increased expression of CXCL10 mRNA CTD PMID:26079696 propiconazole increases expression ISO RGD:1550709 6480464 propiconazole results in increased expression of CXCL10 mRNA CTD PMID:21278054 prostaglandin E2 multiple interactions ISO RGD:1352024 6480464 Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]]] more ... CTD PMID:21913898 protein kinase inhibitor multiple interactions ISO RGD:1352024 6480464 [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to CXCL10 promoter]] more ... CTD PMID:24471457 , PMID:28924041 Pyridostigmine bromide multiple interactions EXP 6480464 [Pyridostigmine Bromide co-treated with DEET co-treated with Permethrin] results in increased expression of and results in increased secretion of CXCL10 protein CTD PMID:28659758 quartz increases secretion EXP 6480464 Quartz results in increased secretion of CXCL10 protein CTD PMID:32976597 quartz multiple interactions EXP 6480464 Tobacco Smoke Pollution promotes the reaction [Quartz results in increased secretion of CXCL10 protein] CTD PMID:32976597 quercetin multiple interactions ISO RGD:1550709 6480464 Quercetin inhibits the reaction [CREBBP protein binds to CXCL10 promoter] more ... CTD PMID:17449583 more ... quercetin decreases secretion ISO RGD:1352024 6480464 Quercetin results in decreased secretion of CXCL10 protein CTD PMID:21756928 , PMID:21967610 quercetin decreases expression ISO RGD:1352024 6480464 Quercetin results in decreased expression of CXCL10 mRNA CTD PMID:21756928 , PMID:21967610 quercetin multiple interactions ISO RGD:1352024 6480464 Quercetin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] more ... CTD PMID:17103373 more ... quinapril hydrochloride decreases expression EXP 6480464 Quinapril results in decreased expression of CXCL10 CTD PMID:15831368 raloxifene multiple interactions ISO RGD:1550709 6480464 Raloxifene Hydrochloride inhibits the reaction [lipopolysaccharide more ... CTD PMID:19533603 remdesivir decreases expression ISO RGD:1352024 30309211 Remdesivir decreases expression of CXCL10 mRNA and protein in SARS-CoV-2 induced hepatocellular carcinoma cells RGD resiquimod multiple interactions ISO RGD:1352024 6480464 [Protein Kinase Inhibitors results in decreased activity of IRAK4 protein] inhibits the reaction [resiquimod promotes the reaction [IRF5 protein binds to CXCL10 promoter]] more ... CTD PMID:28924041 resveratrol decreases expression ISO RGD:1550709 6480464 resveratrol results in decreased expression of CXCL10 mRNA, resveratrol results in decreased expression of CXCL10 protein CTD PMID:21189227 , PMID:21807089 resveratrol decreases secretion ISO RGD:1352024 6480464 resveratrol results in decreased secretion of CXCL10 protein CTD PMID:21756928 , PMID:21967610 resveratrol decreases expression ISO RGD:1352024 6480464 resveratrol results in decreased expression of CXCL10 mRNA CTD PMID:21756928 , PMID:21967610 resveratrol multiple interactions ISO RGD:1352024 6480464 resveratrol inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] more ... CTD PMID:21756928 more ... rifampicin affects expression EXP 6480464 Rifampin affects the expression of CXCL10 protein CTD PMID:25051504 rifampicin multiple interactions ISO RGD:1550709 6480464 [Monocrotaline co-treated with Rifampin co-treated with Phenytoin co-treated with PRKDC] results in increased expression of CXCL10 mRNA CTD PMID:21224054 rimonabant multiple interactions ISO RGD:1550709 6480464 Rimonabant inhibits the reaction [3-(2-hydroxy-4-(1, 1-dimethylheptyl)phenyl)-4-(3-hydroxypropyl)cyclohexanol results in increased expression of CXCL10] CTD PMID:32832534 ritonavir decreases expression ISO RGD:1352024 6480464 Ritonavir results in decreased expression of CXCL10 CTD PMID:26626330 roflumilast multiple interactions ISO RGD:1352024 6480464 Dinoprostone inhibits the reaction [Indomethacin inhibits the reaction [Roflumilast inhibits the reaction [Lipopolysaccharides results in increased secretion of CXCL10 protein]]] more ... CTD PMID:21913898 rolipram decreases secretion ISO RGD:1352024 6480464 Rolipram results in decreased secretion of CXCL10 protein CTD PMID:17996064 rotenone decreases expression EXP 6480464 Rotenone results in decreased expression of CXCL10 mRNA CTD PMID:28374803 rutin multiple interactions ISO RGD:1352024 6480464 Rutin inhibits the reaction [[TNF protein co-treated with IFNG protein] results in increased secretion of CXCL10 protein] CTD PMID:21756928 rutin decreases secretion ISO RGD:1352024 6480464 Rutin results in decreased secretion of CXCL10 protein CTD PMID:21756928 , PMID:21967610 rutin decreases expression ISO RGD:1352024 6480464 Rutin results in decreased expression of CXCL10 mRNA CTD PMID:21756928 , PMID:21967610 ruxolitinib decreases expression ISO RGD:1352024 6480464 ruxolitinib results in decreased expression of CXCL10 mRNA CTD PMID:22941906 ruxolitinib multiple interactions ISO RGD:1352024 6480464 ruxolitinib inhibits the reaction [IFNB1 protein results in increased expression of CXCL10 mRNA], ruxolitinib inhibits the reaction [TNF protein results in increased expression of CXCL10 mRNA] CTD PMID:22941906 , PMID:28365849 S-nitrosoglutathione decreases secretion ISO RGD:1352024 6480464 S-Nitrosoglutathione results in decreased secretion of CXCL10 protein CTD PMID:13678430 serpentine asbestos decreases expression ISO RGD:1352024 6480464 Asbestos, Serpentine results in decreased expression of CXCL10 protein CTD PMID:21148743 serpentine asbestos multiple interactions ISO RGD:1550709 6480464 SPP1 gene mutant form inhibits the reaction [Asbestos, Serpentine results in increased expression of CXCL10 mRNA] CTD PMID:21514415 serpentine asbestos increases expression ISO RGD:1550709 6480464 Asbestos, Serpentine results in increased expression of CXCL10 mRNA CTD PMID:21514415 serpentine asbestos increases expression ISO RGD:1352024 6480464 Asbestos, Serpentine results in increased expression of CXCL10 mRNA CTD PMID:24160326 sevoflurane decreases expression EXP 6480464 sevoflurane results in decreased expression of CXCL10 mRNA CTD PMID:15564938 silicon dioxide multiple interactions ISO RGD:1550709 6480464 [Gold co-treated with Silicon Dioxide] results in increased secretion of CXCL10 protein, GREM1 protein inhibits the reaction [Silicon Dioxide results in increased expression of CXCL10 protein] CTD PMID:22155353 , PMID:27428020 silicon dioxide increases expression ISO RGD:1550709 6480464 Silicon Dioxide results in increased expression of CXCL10 mRNA, Silicon Dioxide results in increased expression of CXCL10 protein CTD PMID:19073995 more ... silicon dioxide increases expression EXP 6480464 Silicon Dioxide results in increased expression of CXCL10 mRNA CTD PMID:22431001 silicon dioxide increases expression ISO RGD:1352024 6480464 Silicon Dioxide analog results in increased expression of CXCL10 mRNA, Silicon Dioxide results in increased expression of CXCL10 mRNA CTD PMID:19428942 more ... silver atom increases secretion EXP 6480464 Silver results in increased secretion of CXCL10 protein CTD PMID:26702581 silver(0) increases secretion EXP 6480464 Silver results in increased secretion of CXCL10 protein CTD PMID:26702581 simvastatin multiple interactions ISO RGD:1550709 6480464 Simvastatin inhibits the reaction [lipopolysaccharide more ... CTD PMID:15187114 simvastatin decreases expression EXP 6480464 Simvastatin results in decreased expression of CXCL10 mRNA, Simvastatin results in decreased expression of CXCL10 protein CTD PMID:16414398 more ... sirolimus decreases expression EXP 6480464 Sirolimus results in decreased expression of CXCL10 mRNA CTD PMID:21865292 sodium arsenite decreases expression ISO RGD:1352024 6480464 sodium arsenite results in decreased expression of CXCL10 mRNA CTD PMID:23876855 sodium arsenite increases expression ISO RGD:1352024 6480464 sodium arsenite results in increased expression of CXCL10 mRNA CTD PMID:29301061 sodium arsenite decreases expression ISO RGD:1550709 6480464 sodium arsenite results in decreased expression of CXCL10 mRNA CTD PMID:21911445 sodium arsenite increases expression ISO RGD:1550709 6480464 sodium arsenite results in increased expression of CXCL10 mRNA CTD PMID:17350061 , PMID:21911445 sodium dodecyl sulfate increases expression ISO RGD:1352024 6480464 Sodium Dodecyl Sulfate results in increased expression of CXCL10 mRNA CTD PMID:17936526 , PMID:31734321 sodium dodecyl sulfate increases expression ISO RGD:1550709 6480464 Sodium Dodecyl Sulfate results in increased expression of CXCL10 mRNA CTD PMID:23445166 sterigmatocystin decreases expression ISO RGD:1550709 6480464 Sterigmatocystin results in decreased expression of CXCL10 mRNA CTD PMID:19818335 sterigmatocystin increases expression ISO RGD:1550709 6480464 Sterigmatocystin results in increased expression of CXCL10 protein CTD PMID:21356202 succimer multiple interactions ISO RGD:1550709 6480464 [Succimer binds to Magnetite Nanoparticles] which results in increased expression of CXCL10 mRNA, [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL10 mRNA CTD PMID:21641980 , PMID:26378955 succimer multiple interactions ISO RGD:1352024 6480464 [Succimer co-treated with Magnetite Nanoparticles] results in increased expression of CXCL10 mRNA CTD PMID:26378955 sumatriptan multiple interactions EXP 6480464 [Naproxen co-treated with Sumatriptan] inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein], Sumatriptan inhibits the reaction [Capsaicin results in increased expression of CXCL10 protein] CTD PMID:22150557 tacrolimus hydrate increases expression EXP 6480464 Tacrolimus results in increased expression of CXCL10 mRNA CTD PMID:21865292 tacrolimus hydrate increases expression ISO RGD:1550709 6480464 Tacrolimus results in increased expression of CXCL10 mRNA CTD PMID:23958496 , PMID:25270620 tamibarotene decreases expression ISO RGD:1550709 6480464 tamibarotene results in decreased expression of CXCL10 mRNA CTD PMID:20861477 tamoxifen decreases expression ISO RGD:1550709 6480464 Tamoxifen results in decreased expression of CXCL10 mRNA CTD PMID:25123088 tamoxifen multiple interactions ISO RGD:1550709 6480464 Tamoxifen inhibits the reaction [lipopolysaccharide more ... CTD PMID:19533603 tamoxifen affects expression ISO RGD:1550709 6480464 Tamoxifen affects the expression of CXCL10 mRNA CTD PMID:20937368 taurocholic acid increases expression ISO RGD:1550709 6480464 Taurocholic Acid results in increased expression of CXCL10 mRNA CTD PMID:21224055 temozolomide increases expression ISO RGD:1352024 6480464 Temozolomide results in increased expression of CXCL10 mRNA CTD PMID:31758290 terbinafine multiple interactions ISO RGD:1352024 6480464 Terbinafine inhibits the reaction [Biological Products results in increased expression of CXCL10 mRNA], Terbinafine inhibits the reaction [Biological Products results in increased expression of CXCL10 protein] CTD PMID:24471457 tert-butyl hydroperoxide increases expression ISO RGD:1550709 6480464 tert-Butylhydroperoxide results in increased expression of CXCL10 mRNA CTD PMID:15003993 Tesaglitazar decreases expression EXP 6480464 tesaglitazar results in decreased expression of CXCL10 mRNA CTD PMID:21515302 testosterone increases expression ISO RGD:1550709 6480464 Testosterone results in increased expression of CXCL10 mRNA CTD PMID:15788153 testosterone undecanoate increases expression ISO RGD:1352024 6480464 testosterone undecanoate results in increased expression of CXCL10 mRNA CTD PMID:19074003 testosterone undecanoate multiple interactions ISO RGD:1352024 6480464 [testosterone undecanoate co-treated with Levonorgestrel] results in increased expression of CXCL10 mRNA CTD PMID:19074003 tetrachloromethane multiple interactions ISO RGD:1550709 6480464 FOXF1 protein affects the reaction [Carbon Tetrachloride results in increased expression of CXCL10 mRNA] more ... CTD PMID:12500195 , PMID:27042213 tetrachloromethane increases expression ISO RGD:1550709 6480464 Carbon Tetrachloride results in increased expression of CXCL10 mRNA, Carbon Tetrachloride results in increased expression of CXCL10 protein CTD PMID:12500195 more ... tetrachloromethane increases expression EXP 6480464 Carbon Tetrachloride results in increased expression of CXCL10 protein CTD PMID:12629582 thalidomide increases expression ISO RGD:1550709 6480464 Thalidomide results in increased expression of CXCL10 CTD PMID:17089043 thioacetamide increases expression EXP 6480464 Thioacetamide results in increased expression of CXCL10 mRNA, Thioacetamide results in increased expression of CXCL10 protein CTD PMID:16337175 more ... titanium dioxide increases expression ISO RGD:1352024 6480464 titanium dioxide results in increased expression of CXCL10 mRNA CTD PMID:19695317 titanium dioxide increases expression EXP 6480464 titanium dioxide results in increased expression of CXCL10 mRNA CTD PMID:30012374 titanium dioxide affects expression ISO RGD:1550709 6480464 titanium dioxide affects the expression of CXCL10 mRNA CTD PMID:29128614 titanium dioxide decreases expression ISO RGD:1550709 6480464 titanium dioxide results in decreased expression of CXCL10 mRNA CTD PMID:29264374 titanium dioxide increases expression ISO RGD:1550709 6480464 titanium dioxide results in increased expression of CXCL10 mRNA, titanium dioxide results in increased expression of CXCL10 protein CTD PMID:21259345 more ... tofacitinib decreases secretion ISO RGD:1352024 6480464 tofacitinib results in decreased secretion of CXCL10 protein CTD PMID:25398374 tofacitinib multiple interactions ISO RGD:1352024 6480464 Cycloheximide inhibits the reaction [tofacitinib inhibits the reaction [TNF protein results in increased expression of CXCL10 protein]] more ... CTD PMID:22121136 , PMID:22941906 tofacitinib decreases expression EXP 6480464 tofacitinib results in decreased expression of CXCL10 mRNA CTD PMID:22899318 tofacitinib decreases expression ISO RGD:1352024 6480464 tofacitinib results in decreased expression of CXCL10 mRNA CTD PMID:22941906 more ... tofacitinib multiple interactions ISO RGD:1550709 6480464 tofacitinib inhibits the reaction [IFNG protein results in increased expression of CXCL10 mRNA] CTD PMID:24213371 toluene 2,4-diisocyanate increases expression ISO RGD:1550709 6480464 Toluene 2, 4-Diisocyanate results in increased expression of CXCL10 mRNA CTD PMID:19647056 , PMID:21404309 topotecan multiple interactions EXP 6480464 [oxaliplatin co-treated with Topotecan] results in increased expression of CXCL10 mRNA CTD PMID:25729387 trametinib multiple interactions ISO RGD:1550709 6480464 trametinib promotes the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA], trametinib promotes the reaction [Poly I-C results in increased expression of CXCL10 mRNA] CTD PMID:25780039 trans-piceid multiple interactions ISO RGD:1352024 6480464 [polydatin co-treated with TGFA protein] results in increased expression of CXCL10 mRNA more ... CTD PMID:21756928 , PMID:21967610 trans-piceid decreases secretion ISO RGD:1352024 6480464 polydatin results in decreased secretion of CXCL10 protein CTD PMID:21756928 , PMID:21967610 trans-piceid decreases expression ISO RGD:1352024 6480464 polydatin results in decreased expression of CXCL10 mRNA CTD PMID:21756928 , PMID:21967610 Tributyltin oxide increases expression ISO RGD:1550709 6480464 bis(tri-n-butyltin)oxide results in increased expression of CXCL10 mRNA CTD PMID:22434021 trichloroethene increases expression EXP 6480464 Trichloroethylene results in increased expression of CXCL10 mRNA CTD PMID:33387578 trimellitic anhydride increases expression EXP 6480464 trimellitic anhydride results in increased expression of CXCL10 mRNA CTD PMID:21893156 triptonide decreases expression ISO RGD:1550709 6480464 triptonide results in decreased expression of CXCL10 mRNA CTD PMID:33045310 troglitazone increases expression ISO RGD:1352024 6480464 troglitazone results in increased expression of CXCL10 mRNA CTD PMID:19631733 ursodeoxycholic acid increases expression EXP 6480464 Ursodeoxycholic Acid results in increased expression of CXCL10 mRNA CTD PMID:15885361 usnic acid multiple interactions ISO RGD:1352024 6480464 [usnic acid co-treated with Lipopolysaccharides] results in decreased expression of CXCL10 mRNA CTD PMID:22777745 valproic acid decreases expression ISO RGD:1352024 6480464 Valproic Acid results in decreased expression of CXCL10 mRNA CTD PMID:29154799 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CXCL10 mRNA CTD PMID:17202759 valsartan multiple interactions ISO RGD:1550709 6480464 Valsartan inhibits the reaction [AGT protein results in increased expression of CXCL10 mRNA], Valsartan inhibits the reaction [AGT protein results in increased expression of CXCL10 protein] CTD PMID:18716376 vinclozolin decreases expression EXP 6480464 vinclozolin results in decreased expression of CXCL10 mRNA CTD PMID:15686871 vincristine increases expression ISO RGD:1352024 6480464 Vincristine results in increased expression of CXCL10 mRNA CTD PMID:23649840 zinc atom multiple interactions ISO RGD:1550709 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL10 mRNA more ... CTD PMID:23503329 , PMID:24155903 zinc atom decreases expression ISO RGD:1550709 6480464 Zinc deficiency results in decreased expression of CXCL10 mRNA CTD PMID:24155903 zinc protoporphyrin multiple interactions ISO RGD:1550709 6480464 zinc protoporphyrin inhibits the reaction [ADIPOQ protein inhibits the reaction [Lipopolysaccharides results in increased expression of CXCL10 mRNA]] CTD PMID:20861358 zinc(0) multiple interactions ISO RGD:1550709 6480464 [Zinc co-treated with Nickel co-treated with Cobalt co-treated with 1-Methyl-3-isobutylxanthine co-treated with Dexamethasone co-treated with INS1 protein] results in increased expression of CXCL10 mRNA more ... CTD PMID:23503329 , PMID:24155903 zinc(0) decreases expression ISO RGD:1550709 6480464 Zinc deficiency results in decreased expression of CXCL10 mRNA CTD PMID:24155903 zoledronic acid increases expression ISO RGD:1352024 6480464 zoledronic acid results in increased expression of CXCL10 mRNA CTD PMID:24714768
